In this Gamechangers episode, Professor Thomas Danne presents a study that has stimulated research in many ways, evaluating the link between the calcium channel blocker verapamil and improved beta cell function. Watch the episode below to uncover how a decades-old blood pressure drug may modify the course of diabetes.

Read about Thomas Danne’s Gamechangers pick here. At the time of filming, two more trials investigating the effect of the verapamil on preserving beta cell function in newly diagnosed type 1 diabetes were still ongoing, as mentioned by Danne. Both have since been published. Explore the findings from the US study on adults here and the INNODIA study in a paediatric population here.